tiprankstipranks
Trending News
More News >
Inhibitor Therapeutics Inc. (INTI)
OTHER OTC:INTI
US Market

Inhibitor Therapeutics (INTI) Similar Stocks

Compare
29 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Inhibitor Therapeutics
$0.04
$7.23M
-54.44%
Relmada Therapeutics
$0.75
$24.89M
-75.65%
0 Buy
2 Hold
0 Sell
Hold
Predictive Oncology
$0.88
$7.86M
-38.46%
0 Buy
0 Hold
0 Sell
Hold
Immuron
$1.77
$10.08M
-23.04%
Intelligent Bio Solutions
$1.41
$9.74M
-40.25%
Neuphoria Therapeutics
$6.64
$12.49M
-34.08%
0 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INTI
Inhibitor Therapeutics
0.04
-0.05
-55.56%
RLMD
Relmada Therapeutics
0.75
-2.33
-75.65%
POAI
Predictive Oncology
0.88
-0.57
-39.31%
IMRN
Immuron
1.77
-0.53
-23.04%
INBS
Intelligent Bio Solutions
1.41
-0.95
-40.25%
NEUP
Neuphoria Therapeutics
6.64
-2.96
-30.83%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis